MARAMAI SAMUELE | Professor page

Ciccone, V., Cecchin, C., Frosini, M., Saletti, M., Maramai, S., Giuliani, G., et al. (2026). VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES [10.1016/j.ejps.2025.107422]. - view more
Corallo, A.A., Maramai, S., Noli, C., Paolino, M., Brizzi, A., Ligresti, A., et al. (2026). Targeting TRPA1 with Novel Synthetic Compounds Based on Different Scaffolds to Reduce Acute and Chronic Pain. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 27(4) [10.3390/ijms27041716]. - view more
Maramai, S., Mugnaini, C., Paolino, M., Schiano Moriello, A., De Petrocellis, L., Corelli, F., et al. (2025). Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists. MOLECULES, 30(3) [10.3390/molecules30030721]. - view more
Poggialini, F., Governa, P., Vagaggini, C., Maramai, S., Lamponi, S., Mugnaini, C., et al. (2025). Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 209 [10.1016/j.ejps.2025.107066]. - view more
Paolino, M., Saletti, M., Venditti, J., Castriconi, F., Giuliani, G., Maramai, S., et al. (2025). Use of imidazo[1,5-a]quinoline scaffold as the pharmacophore in the design of bivalent ligands of central benzodiazepine receptors. BIOORGANIC & MEDICINAL CHEMISTRY, 117 [10.1016/j.bmc.2024.118006]. - view more